10 - Cart multiple with image at left
OUR HISTORY
From a Moroccan family business to a leading regional group
Feu Omar Tazi
Founder of Sothema
Founded in 1976 by the late Omar Tazi, Sothema was born of a deep conviction: to contribute to the emergence of a Moroccan pharmaceutical industry serving the country's health sovereignty. This founding dream has become an exceptional journey.
Today, Sothema is the first Moroccan pharmaceutical company listed on the Casablanca Stock Exchange, and an industrial player whose reach now extends across an entire region. Over decades, Sothema has established itself as an essential regional pillar, present in Morocco, sub-Saharan Africa and the Middle East.
Backed by a long-standing cooperation with more than 50 leading international partners, and true to its founder's visionary legacy, Sothema continues to invest in innovation and industrial excellence to meet today's health challenges and anticipate those of tomorrow.
14 - conent and image on left and key figure
1976 - 2026: 50 years in the service of health
In 2026, Sothema celebrates half a century of commitment to healthcare in Morocco, Africa and the Middle East.
Fifty years of strengthening Morocco's therapeutic sovereignty. Fifty years of guaranteeing access to high-quality, affordable healthcare. Fifty years of placing the patient at the heart of every decision, with the conviction that everyone's health is the foundation of collective progress.
Half a century of passion, high standards and commitment - a legacy that engages and inspires us.
Today, with over 350 medicines marketed, 50 partner laboratories and more than 1,600 employees, Sothema enters this new chapter with the same founding ambition:
Healing Tomorrow.
50
years of commitment
+350
products
+50
international partners
+1 600
employees
32 - Timeline
OUR KEY MILESTONES
50 years of our journey in a few dates
Creation of Sothema
Inauguration of the Bouskoura site
Start of insulin and injectable solutions production
Start of contract manufacturing
Penicillin unit launch
Launch of the cephalosporin unit
Inauguration of the Large-Volume Parenterals (LVP) unit
First stone laid for West Afric Pharma subsidiary in Senegal
Introduction to the stock market
Sterile blocks unit launch
Acquisition of the Novartis Morocco site
Manufacturing of the First Biotech-derivered anti-cancer products in Morocco
1st patent resulting from fundamental research in Moroccan antibiotic therapy
Inauguration of biosimilars unit. Opening of 2nd production site for serums in flexible bags. Launch of a biomass boiler.
1st clinical trial of an anti-Covid-19 vaccine candidate in Africa
Stakeholdings in Prodimedic and Ziwig
Inauguration of Axess Pharma
2 new sites in Ivory Coast and Saudi Arabia
Acquisition of Soludia